VeriSign
VRSN
294.22
+1.12
+0.38%
VeriSign
US · VRSN
#776 by market cap
Listed 1970
294.22
+1.12
+0.38%
Live - 5344 symbols - heartbeat 549s ago
· 2026-10-08 07:40
Pre-market
294.22
0.00%
After-hours
294.22
0.00%
- Market cap
- 26.57B
- P/E (TTM)i
- 31.95
- P/Bi
- -11.79
- EPSi
- 8.81
- Div yieldi
- 1.07%
- 52W posi
- 83%
Reader sentiment
Are you bullish or bearish on VRSN?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is -4.43, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +6.37% YoY
Margins
- Gross margin
- 88.15%
- Operating margin
- 67.67%
- Net margin
- 49.84%
Key ratios & quality
- Enterprise valuei
- 27.78B
- PEG ratioi
- 4.56
- Altman Z-Scorei
- -4.43
PEG uses trailing P/E against the 3-year net income growth rate (7.01%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.21B | 1.23B | 1.27B | 1.33B | 1.42B | 1.49B | 1.56B | 1.66B |
| Gross profit | 1.02B | 1.05B | 1.08B | 1.14B | 1.22B | 1.30B | 1.37B | 1.46B |
| Selling & admin expenses | 197.56M | 184.26M | 186.00M | 188.40M | 195.40M | 204.20M | 211.10M | 235.70M |
| Research & development | 57.88M | 60.81M | 74.67M | 80.50M | 85.70M | 91.00M | 96.70M | 103.60M |
| Operating profit | 767.39M | 806.13M | 824.20M | 866.80M | 943.10M | 1.00B | 1.06B | 1.12B |
| Pretax profit | 729.52M | 758.78M | 750.24M | 782.20M | 880.20M | 976.50M | 1.02B | 1.07B |
| Tax | 147.03M | 146.48M | -64.64M | -2.60M | 206.40M | 158.90M | 236.20M | 242.80M |
| Net profit | 582.49M | 612.30M | 814.89M | 784.80M | 673.80M | 817.60M | 785.70M | 825.70M |
| Basic EPS | 5 | 5 | 7 | 7 | 6 | 8 | 8 | 9 |
| Diluted EPS | 4.75 | 5.15 | 7.07 | 7.00 | 6.24 | 7.90 | 8.00 | 8.81 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 402.30M | 409.90M | 419.10M | 425.30M | 428.90M | 434.60M |
| Gross profit | 352.90M | 360.80M | 370.30M | 376.30M | 379.70M | 384.60M |
| Selling & admin expenses | 55.70M | 54.40M | 60.60M | 65.00M | 58.60M | 60.80M |
| Research & development | 26.00M | 25.70M | 25.40M | 26.50M | 27.50M | 27.50M |
| Operating profit | 271.20M | 280.70M | 284.30M | 284.80M | 293.60M | 296.30M |
| Pretax profit | 258.40M | 267.30M | 271.70M | 271.10M | 279.40M | 281.60M |
| Tax | 59.10M | 59.90M | 58.90M | 64.90M | 64.90M | 65.10M |
| Net profit | 199.30M | 207.40M | 212.80M | 206.20M | 214.50M | 216.50M |
| Basic EPS | 2 | 2 | 2 | 2 | 2 | 2 |
| Diluted EPS | 2.10 | 2.21 | 2.27 | 2.23 | 2.34 | 2.38 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.32B | 1.28B | 1.22B | 1.27B | 1.04B | 988.30M | 663.80M | 652.50M |
| Cash & ST investments | 1.27B | 1.22B | 1.17B | 1.21B | 980.40M | 926.40M | 599.90M | 580.50M |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 1.91B | 1.85B | 1.77B | 1.98B | 1.73B | 1.75B | 1.41B | 1.33B |
| Total current liabilities | 947.59M | 965.17M | 988.69M | 1.07B | 1.12B | 1.19B | 1.53B | 1.33B |
| Short-term debt | -- | -- | -- | -- | 5.50M | 5.10M | 305.00M | 5.80M |
| Long-term debt | 1.79B | 1.79B | 1.79B | 1.79B | 1.79B | 1.79B | 1.49B | 1.79B |
| Total liabilities | 3,299,978,000.00 | 3,344,109,000.00 | 3,157,108,000.00 | 3,244,300,000.00 | 3,295,600,000.00 | 3,330,000,000.00 | 3,364,400,000.00 | 3,480,100,000.00 |
| Total equity | -1.39B | -1.49B | -1.39B | -1.26B | -1.56B | -1.58B | -1.96B | -2.15B |
| Retained earnings | -17.09B | -16.48B | -15.66B | -14.88B | -14.20B | -13.39B | -12.60B | -11.78B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 714.10M | 682.30M | 688.40M | 652.50M | 626.00M | 1.12B |
| Cash & ST investments | 648.50M | 593.80M | 617.70M | 580.50M | 556.40M | 1.03B |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 1.45B | 1.41B | 1.40B | 1.33B | 1.30B | 1.80B |
| Total current liabilities | 1.29B | 1.26B | 1.31B | 1.33B | 1.36B | 1.90B |
| Short-term debt | 5.40M | 4.70M | 6.00M | 5.80M | 5.80M | 555.20M |
| Long-term debt | 1.79B | 1.79B | 1.79B | 1.79B | 1.79B | 1.79B |
| Total liabilities | 3,424,700,000.00 | 3,401,600,000.00 | 3,454,200,000.00 | 3,480,100,000.00 | 3,510,600,000.00 | 4,056,900,000.00 |
| Total equity | -1.98B | -1.99B | -2.05B | -2.15B | -2.21B | -2.25B |
| Retained earnings | -12.40B | -12.19B | -11.98B | -11.78B | -11.56B | -11.34B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 697.77M | 753.89M | 730.18M | 807.20M | 831.10M | 853.80M | 902.60M | 1.09B |
| Depreciation & amortization | 48.37M | 46.33M | 46.35M | 47.90M | 46.90M | 44.10M | 36.90M | 31.20M |
| Free cash flow | 660.76M | 713.58M | 686.79M | 754.20M | 803.70M | 808.00M | 874.50M | 1.07B |
| Dividends paid | -- | -- | -- | -- | -- | 0 | 0 | -215.20M |
| Stock buybacks / issuance | -638.15M | -782.58M | -777.45M | -722.60M | -1.05B | -901.40M | -1.23B | -881.60M |
| Ending cash balance | 366.75M | 517.60M | 410.60M | 228.80M | 379.00M | 245.50M | 212.10M | 309.50M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 291.30M | 202.50M | 307.70M | 289.60M | 272.40M | 231.60M |
| Depreciation & amortization | 8.90M | 8.30M | 7.30M | 6.70M | 6.40M | 6.60M |
| Free cash flow | 285.50M | 194.70M | 303.00M | 285.10M | 265.20M | 212.80M |
| Dividends paid | 0 | -72.10M | -72.00M | -71.10M | -74.20M | -73.60M |
| Stock buybacks / issuance | -241.70M | -166.80M | -218.70M | -254.40M | -225.40M | -201.40M |
| Ending cash balance | 580.80M | 319.60M | 237.00M | 309.50M | 478.30M | 842.50M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -- | -- | -- | -- | -- | -- | -- | -- |
| ROA %i | 23.99 | 32.50 | 45.01 | 41.85 | 36.25 | 46.96 | 49.80 | 60.44 |
| ROIC %i | -- | -- | -- | -- | -- | -- | -- | -- |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 69.21 | 68.67 | 66.19 | 65.19 | 67.06 | 70.44 | 70.45 | 69.15 |
| FCF / sales %i | 54.38 | 57.94 | 54.29 | 56.80 | 56.40 | 54.12 | 56.15 | 64.49 |
| Current ratioi | 1.39 | 1.32 | 1.23 | 1.18 | 0.93 | 0.83 | 0.43 | 0.49 |
| Quick ratioi | 1.35 | 1.28 | 1.19 | 1.13 | 0.89 | 0.79 | 0.40 | 0.45 |
| Debt / assetsi | 93.24 | 96.66 | 101.60 | 90.14 | 103.55 | 102.77 | 128.08 | 135.61 |
| LT debt / equityi | -- | -- | -- | -- | -- | -- | -- | -- |
| Interest coveragei | 7.55 | 9.72 | 9.62 | 10.40 | 12.69 | 13.97 | 14.57 | 14.88 |
| Revenue CAGR (3Y) %i | 4.67 | 2.55 | 2.78 | 3.00 | 4.98 | 5.68 | 5.47 | 5.15 |
| Net income CAGR (3Y) %i | 15.79 | 11.59 | 21.24 | 10.45 | 3.24 | 0.11 | 0.04 | 7.01 |
| FCF CAGR (3Y) %i | 1.64 | 10.88 | 1.68 | 4.51 | 4.04 | 5.57 | 5.06 | 9.95 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -- | -- | -- | -- | -- | -- |
| ROA %i | 49.81 | 54.89 | 56.60 | 60.44 | 61.27 | 52.95 |
| ROIC %i | -- | -- | -- | -- | -- | -- |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 70.02 | 69.55 | 69.00 | 69.15 | 69.22 | 69.07 |
| FCF / sales %i | 57.54 | 59.44 | 61.79 | 64.49 | 62.26 | 62.42 |
| Current ratioi | 0.56 | 0.54 | 0.53 | 0.49 | 0.46 | 0.59 |
| Quick ratioi | 0.50 | 0.49 | 0.48 | 0.45 | 0.42 | 0.56 |
| Debt / assetsi | 123.76 | 127.26 | 127.78 | 135.61 | 138.34 | 129.81 |
| LT debt / equityi | -- | -- | -- | -- | -- | -- |
| Interest coveragei | 14.36 | 14.46 | 14.60 | 14.88 | 15.41 | 15.54 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Quote time 2026-10-08 07:40:14 · For reference only, not investment advice and not tailored to your situation.